HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their immune-fighting CD4+ T-cells to normal levels, researchers reported Nov. 24 in JAMA Internal Medicine.
25 November 2014 | Infection Control Today
I am not going to be here for the cure. I am not going to see the end of AIDS. And neither will you.
17 November 2014 | The Body
The human immunodeficiency virus (HIV) can insert itself at different locations in the DNA of its human host -- and this specific integration site determines how quickly the disease progresses, report researchers at KU Leuven's Laboratory for Molecular Virology and Gene Therapy. The study was published online today in the journal Cell Host & Microbe.
13 November 2014 | Leuven University, via Eurekalert
On November 5th The European AIDS Treatment Group (EATG) announced the launch of an audit designed to assess current and future levels of investment in research into a cure for HIV. Yet, while there have been significant advances in the prevention and treatment of HIV, there is no cure.
13 November 2014 | EATG
We respond to infections in two fundamental ways. One is 'resistance,' where the body attacks the invading pathogen and reduces its numbers. Another, which is much less well understood, is 'tolerance,' where the body tries to minimize the damage done by the pathogen. A study using data from a large Swiss cohort of HIV-infected individuals gives us a glimpse into why some people cope with HIV better than others.
12 November 2014 | Science Daily
French scientists believe they have identified the means by which two HIV-positive men have been “spontaneously cured,” and that this insight may carve a new cure pathway.
11 November 2014 | AIDSmeds.com
French scientists claimed Tuesday to have found the genetic mechanism for a "spontaneous cure" in two HIV-infected men, proposing a new strategy for combating AIDS even as other experts urged caution.
10 November 2014 | AFP / Yahoo News
SPANISH scientists have embarked on pioneering clinical trials to find out whether HIV can be cured with stem cells from umbilical cords. Only 1% of umbilical cords have the right genetic mutation to enable blood extracted from them to wipe out HIV – a mutation known as the CCR5 Delta 32.
07 November 2014 | Think Spain
A new clinical trial is exploring whether giving anti-HIV therapy soon after birth to infants who became infected with HIV in the womb leads to remission of the virus, enabling the children eventually to stop treatment for an extended time period. The trial aims to build on the case of the 'Mississippi Baby'.
05 November 2014 | National Institute of Allergy and Infectious Diseases (NIAID) press release
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and collaborators from Heidelberg University, in the joint Molecular Medicine Partnership Unit, have obtained the first structure of the immature form of HIV at a high enough resolution to pinpoint exactly where each building block sits in the virus. The study, published online today in Nature, reveals that the building blocks of the immature form of HIV are arranged in a surprising way.
04 November 2014 | Medical Xpress